Viewing Study NCT05565560


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-01-04 @ 4:30 PM
Study NCT ID: NCT05565560
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-19
First Post: 2022-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Plaque Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Plaque Psoriasis View
None Apremilast View
None AMG 407 View
None Moderate to Severe Plaque Psoriasis View
None Pediatric Plaque Psoriasis View